Product/Service
Gastronintestinal Clinical Trials
Source: ICON
ICON has extensive experience in conducting gastrointestinal studies across the entire drug development spectrum, ranging from the initial studies in Phase I through post-marketing efforts in Phase IV.
Click Here To Download:
•Brochure: Clinical Research Overview
•Brochure: Clinical Research Overview
•Brochure: Clinical Research Overview
ICON has extensive experience in conducting gastrointestinal studies across the entire drug development spectrum, ranging from the initial studies in Phase I through post-marketing efforts in Phase IV. In the past five years, ICON has conducted approximately 80 clinical gastrointestinal studies, assessing over 18,500 patients at 3,600 sites worldwide.
Our clinical trial experience includes but is not limited to the following gastrointestinal indications:
- Acute Pancreatitis
- Colorectal Conditions
- Constipation
- Crohn's Disease
- Inflammatory Bowel Disease
- Irritable Bowel Disease
- Diarrhea
- Dyspepsia
- Gastroenteritic Infections
- Gastroesophageal Reflux
- Liver Cirrhosis
- Esophagitis
- Ulcerative Colitis
•Brochure: Clinical Research Overview
